ClariVest Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

ClariVest Asset Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-19,697	Closed	-$216K	–	761
2017 Q1	$216K	Sell	19,697 -35,103	-64%	-$407K	0.01%	478
2016 Q4	$743K	Buy	+54,800	New	+$764K	0.02%	370
2015 Q1	–	Sell	-800	Closed	-$12K	–	671
2014 Q4	$12K	Buy	+800	New	+$8.45K	﹤0.01%	456

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClariVest Asset Management's SCMP Position: Q2 2017 in Review

ClariVest Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2017, closing a stake of 19,697 shares — an estimated $216K sold.

ClariVest Asset Management first reported a position in SCMP in Q4 2014 and held it in 3 quarters. The position peaked at $743K in Q4 2016. 167 funds tracked by Wall St. Rank hold SCMP as of Q2 2017.

ClariVest Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
ClariVest Asset Management sold 19,697 Sucampo Pharmaceuticals, Inc. shares in Q2 2017, an estimated $216K.
ClariVest Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 3 quarters.
ClariVest Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $743K in Q4 2016.
167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2017.

Based on ClariVest Asset Management's 13F filing for Q2 2017, filed 2 Aug 2017.